Engineering time-controlled immunotherapy.
Where this comes from
- Record sourced from PubMed, PMID 36520890.
- Also identified by DOI 10.1126/science.adf5318.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Designer lymphocytes expand the dynamic range of possibilities for treating disease.
Medical subject headings
- Neoplasms
- Immunotherapy, Adoptive
- T-Lymphocytes
- Receptors, Chimeric Antigen